Induction of Dreaming With EEG and Anesthesia in Healthy Adults (NCT07198711) | Clinical Trial Compass
By InvitationPhase 1
Induction of Dreaming With EEG and Anesthesia in Healthy Adults
United States15 participantsStarted 2025-05-20
Plain-language summary
This open-label, randomized crossover study in healthy adults tests two propofol protocols to produce distinct experiential states. One induces brief loss of responsiveness with spontaneous emergence, intended to elicit dream reports; the other maintains light sedation without loss of responsiveness, intended to elicit non-dream experiences while participants remain responsive. The main goals are to (a) measure the protocol-concordant experiential report rate (how often each method produces its intended experience), (b) explore EEG correlates of these experiences in the two states, and (c) describe their phenomenology (what they are like). We will also examine short-term changes in well-being and sleep related to these experiences. Participants complete four sessions (two of each method) with EEG and routine monitoring, immediate post-session interviews, and brief questionnaires and daily sleep/dream logs before and after anesthesia sessions.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Male or female, 18 to 70 years of age, inclusive, at screen.
✓. Able to read, understand, and provide written, dated informed consent prior to screening. Participants will be deemed likely to comply with study protocol and communicate with study personnel about adverse events and other clinically important information.
✓. In sufficiently good health to proceed with a low risk elective procedure, characterized using the American Society of Anesthesiologists (ASA) physical status classification system as Class 1 or 2.
✓. If female, a status of non-childbearing potential or use of an acceptable form of birth control
✓. Body mass index between 17-35 kg/m2.
Exclusion criteria
✕. Female of childbearing potential who is not willing to use one of the specified forms of birth control during the study.
✕. Female that is pregnant or breastfeeding.
✕. Female with a positive pregnancy test at screening or baseline.
What they're measuring
1
Protocol-concordant experiential report
Timeframe: Assessed within 5 minutes of return of responsiveness (LOR protocol) or within 5 minutes of session end (light-sedation protocol).
. Current diagnosis of a Substance Use Disorder (SUD; Abuse or Dependence, as defined by DSM-V) rated "moderate" or "severe", or Alcohol Use Disorder rated "moderate" or "severe". The following categories of SUD will NOT be excluded: nicotine dependence; alcohol or substance use disorder rated "mild"; alcohol or substance use disorder of any severity in remission, either early (3-12 months) or sustained (\>12 months) time frames.
✕. Current diagnosis of Axis I disorders other than Dysthymic Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder, Panic Disorder, Agoraphobia, Specific Phobia, or Bipolar II Disorder
✕. History of schizophrenia or schizoaffective disorders, or any history of psychotic symptoms
✕. History of anorexia nervosa, bulimia nervosa, or eating disorder not otherwise specified, within five years of screening.
✕. In the judgment of the investigator, the subject is at significant risk for suicidal behavior during the course of his/her participation in the study.